DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer

Por Drouillard, A, Puleo, F, Bachet, J B, Ouazzani, S, Calomme, A, Demetter, P, Verset, G, Van Laethem, J L, Maréchal, R
Publicado no Br J Cancer (2016)